Study identifies novel inhibitors against SARS-CoV-2 main pr

In a recent study posted to the bioRxiv* server, researchers at the University of Arizona screened ~11 million severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) main protease (MPro)-inhibiting small compounds in the ZINC15 database using a structure-based in-silico screening method.

Related Keywords

Aimee Molineux , Neha Mathurnov , Neha Mathur , Research Collaboratory , Protein Data Bank , Lab Diagnostics Automation , University Of Arizona , Lab Diagnostics Automation Industry , Automation Industry Focus , Structural Bioinformatics , Coronavirus Disease Covid 19 , Cars , Ars Cov 2 , Coronavirus , Cytotoxicity , N Vitro , Micron , Olymerase , Espiratory , Na , Evere Acute Respiratory , Evere Acute Respiratory Syndrome , Yndrome , Vaccine ,